Section Arrow
Quote
ARWR.NASDAQ
- Arrowhead Pharmaceuticals
Quotes are at least 15-min delayed:2026/09/30 18:33 EDT
After Hours
Last
 65.14
-0.31 (-0.47%)
Bid
64.85
Ask
68.42
High 65.4507 
Low 65.14 
Volume 56.61K 
Regular Hours (Closed)
Last
 65.45
-0.8 (-1.21%)
Day High 
66.8 
Prev. Close
66.25 
1-M High
87.2 
Volume 
1.74M 
Bid
64.85
Ask
68.42
Day Low
65.09 
Open
66.8 
1-M Low
63.99 
Market Cap 
9.36B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 67.13 
20-SMA 74.85 
50-SMA 81.93 
52-W High 95.4899 
52-W Low 34.61 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.28/-3.87
Enterprise Value
9.68B
Balance Sheet
Book Value Per Share
3.30
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
829.45M
Operating Revenue Per Share
1.81
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CNTBConnect Biopharma Holdings Limited1.1+0.108+10.89%-- 
After Hours 1.11 +0.01 +0.91%
AEONAEON Biopharma0.3+0.041+15.83%-- 
After Hours 0.2935 -0.0065 -2.17%
VBIOValion Bio Inc.2.8-0.03-1.06%-- 
After Hours 2.82 +0.02 +0.71%
RXRXRecursion Pharmaceuticals4.13+0.1+2.48%-- 
After Hours 4.1309 +0.0009 +0.02%
IOVAIovance Biotherapeutics14.82+0.37+2.56%-- 
After Hours 14.8296 +0.0096 +0.06%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products andclinical candidates designed to target different cell types within the body.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.